|
Market Closed -
Australian S.E.
02:10:20 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 8.240 AUD | +2.74% |
|
-20.16% | -33.87% |
| 08-28 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 08-27 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 290M | |||||
| 79.79B | |||||
| 58.85B | |||||
| 56.03B | - | ||||
| 51.26B | |||||
| 47.68B |
Select your edition
All financial news and data tailored to specific country editions
